Stockholm exchange outlook positive on oil price decline; AstraZeneca reports clinical trial setback

The Stockholm Stock Exchange is expected to open higher following a significant drop in global oil prices. Simultaneously, AstraZeneca has disclosed a negative outcome in a clinical study, which may weigh on the company's equity performance.